Introduction Cytoreductive surgery has been used a part of multimodality treatment in
patients with malignant pleural mesothelioma (MPM). The residual microscopic disease that …

Simple Summary Treatment of malignant mesothelioma with high-temperature
chemotherapeutic instillation of the affected pleural space seems to be advantageous, but …

Background The exact role and type of surgery for malignant pleural mesothelioma (MPM)
remains controversial. This study aimed at analyzing a 20-year single center perioperative …

Simple Summary There continues to be little research in the literature on perioperative
outcomes after cytoreductive surgery (CRS) combined with intraoperative hyperthermic …

OBJECTIVES Recurrence of thymoma is described in 10–30% of cases after surgical
resection. Iterative surgery for thymoma pleural relapses (TPRs) is often part of a multimodal …

While reading the last guidelines of the task force of the ERS/EACTS/ESTS/ESCRO on
treatment of malignant pleural mesothelioma (MPM)(1) we noted that hyperthermic …

Introduction: Malignant Pleural Mesothelioma (MPM) is characterized by an aggressive
behavior and an inevitably fatal prognosis, whose treatment is still far from being …

The safety and efficacy of hyperthermic intrathoracic chemotherapy (HITHOC) as an adjunct
to cytoreductive surgery (CRS) in pleural malignancies has been well demonstrated. This is …

Background Objective of this study was to assess postoperative morbidity and mortality as
well as recurrence-free and overall survival in patients with thymic malignancies and pleural …

Hyperthermic intrathoracic chemotherapy (HITHOC) adjunct to surgery for Malignant Pleural
Mesothelioma (MPM) has no definite role. The primary objective of this pilot-trial was to …